Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Exchange Rate Effect (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Exchange Rate Effect for 2 consecutive years, with $295406.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 206.76% to $295406.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $410526.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$3750.0 for FY2025, 104.87% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was $295406.0 at Neuphoria Therapeutics, up from -$19455.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $295406.0 in Q4 2025, with the low at -$276692.0 in Q4 2024.